From Beth Lewin Dean <[email protected]>
Subject Update: Live Q&A on Epilepsy, COVID-19, and Insurance
Date April 13, 2020 8:53 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
CURE - Citizens United for Research in Epilepsy

[link removed] roster for tomorrow's live Q&A on epilepsy and COVID-19 has grown! Tomorrow, April 14 at 11:00AM CT, Benjamin Isgur, Health Research Institute Leader at PwC United States, will join pediatric epileptologist Dr. James Wheless and BlueCross BlueShield Illinois Medical Director Dr. Tony R. Vancauwelaert to answer YOUR questions via Facebook Live stream ([link removed]) .

Ask these experts about epilepsy management, trends in medication availability, and working with insurance companies during the COVID-19 pandemic ahead of the event through Facebook Messenger ([link removed]) . You can also join us live to ask questions in the chat during the stream.

Like us on Facebook ([link removed]) to get a notification when we go live! If you can’t join us live, you can view the archived stream on our Facebook page or on our website.

Be well,
5a0b940e-4dde-4325-ad3d-5f1255ffab18.png

Beth Lewin Dean, CEO

------------------------------------------------------------

Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed] [link removed] [link removed] [link removed] [link removed]

View this email in your browser. ([link removed])

Our mailing address is:
Citizens United for Research in Epilepsy (CURE)
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Update your preferences ([link removed]) or unsubscribe from this list ([link removed])
In the past you provided Citizens United for Research in Epilepsy your email address. Occasionally, you will receive updates from CURE about epilepsy research and news.
Screenshot of the email generated on import

Message Analysis